The goal of this study is to evaluate the feasibility and preliminary efficacy of a combined acupuncture and exercise intervention for the management of chemot…

Metastatic Bladder CancerPeripheral NeuropathyAdvanced Urothelial Cancer+3 more

~Estimated

~$10 – $7,500

Dana-Farber Cancer InstituteNCT07548476

Phase 1

A Phase 1, Open-Label Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of GB-4362 Administered With Enfortumab Vedotin and Pembrolizumab in Participants With Advanced Urothelial Cancer

The purpose of this study is to evaluate the safety and tolerability of an investigational drug called GB-4362 when it is given together with enfortumab vedoti…

Advanced Urothelial CancerMetastatic Urothelial Carcinoma

~Estimated

~$10 – $7,500

Generate BiomedicinesNCT07484022